Seyed Ramin Radfar

Citirano

	Sve	Od 2019.
Citati	798	632
H-indeks	12	12
i10-indeks	15	12

160

120

201120122013201420152016201720182019202020212022202320245 4 3 10 13 34 36 55 36 111 132 158 160 33

Javni pristup

Prikaži sve

5 članaka

0 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Ali FarhoudianTehran University of Medical SciencesPotvrđena adresa e-pošte na sina.tums.ac.ir
Hamed Ekhtiari, MD, PhD,Laureate Institute for Brain ResearchPotvrđena adresa e-pošte na laureateinstitute.org
Alireza NorooziAssistant Professor of Psychiatry, Iranian National Center for Addiction Studies, Tehran, IranPotvrđena adresa e-pošte na razi.tums.ac.ir
Pardis NematollahiIsfahan University of Medical ScienceSPotvrđena adresa e-pošte na med.mui.ac.ir
masud yunesianProfessor of Epidemiology, Tehran University of Medical SciencesPotvrđena adresa e-pošte na tums.ac.ir
Kathleen T BradyProfessor of Psychiatry, Medical University South CarolinaPotvrđena adresa e-pošte na musc.edu
Omid MassahUniversity of Social Welfare and Rehabilitation Sciences, Substance Abuse and Dependence ResearchPotvrđena adresa e-pošte na uswr.ac.ir
Schwann ShariatiradSubstance Abuse and Dependence Research Center, University of Social Welfare and RehabilitationPotvrđena adresa e-pošte na uswr.ac.ir
Christian G. Schütz (Schuetz, Schutz)University of British Columbia UBCPotvrđena adresa e-pošte na ubc.ca
SARAH J COUSINSUCLA Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human BehaviorPotvrđena adresa e-pošte na g.ucla.edu
Geert DomAntwerp UniversityPotvrđena adresa e-pošte na uantwerpen.be
Nicolas ClarkMonash UniversityPotvrđena adresa e-pošte na mh.org.au
Giuseppe Carra'University of Milan BicoccaPotvrđena adresa e-pošte na unimib.it
Arash Tehrani-BanihashemiIran University of Medical Sciences, Preventive Medicine and Public Health Research CenterPotvrđena adresa e-pošte na iums.ac.ir
Desiree A. Crevecoeur-MacPhail, PhDUCLA Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human BehaviorPotvrđena adresa e-pošte na ucla.edu
Seyed Sepehr HashemianStagiaire postdoctoral Département des sciences de la santé communautaire Université de SherbrookePotvrđena adresa e-pošte na usherbrooke.ca
Reza DaneshmandSubstance Abuse and Dependence Research Center,University of Social Welfare and RehabilitationPotvrđena adresa e-pošte na uswr.ac.ir
Abbas MotevalianProfessor of Epidemiology, Iran University of Medical SciencesPotvrđena adresa e-pošte na iums.ac.ir
Mohammad FarhadiENT and Head&Neck Research Center, Iran University of Medical SciencesPotvrđena adresa e-pošte na iums.ac.ir

Prati

Seyed Ramin Radfar

Department of Neuroscience and Addiction, School of Advanced Technologies in Medicine (SATiM)

Potvrđena adresa e-pošte na razi.tums.ac.ir

Substance Use Disorders harm reduction HIV/AIDS Prevention Drug


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
Current research on methamphetamine: epidemiology, medical and psychiatric effects, treatment, and harm reduction efforts SR Radfar, RA Rawson Addiction & health 6 (3-4), 146, 2014	142	2014
COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. an international society of addiction medicine practice and policy interest group … A Farhoudian, A Baldacchino, N Clark, G Gerra, H Ekhtiari, G Dom, ... Basic and Clinical Neuroscience 11 (2), 133, 2020	135	2020
Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey SR Radfar, CAJ De Jong, A Farhoudian, M Ebrahimi, P Rafei, M Vahidi, ... Frontiers in Psychiatry 12, 639393, 2021	79	2021
A global survey on changes in the supply, price, and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic A Farhoudian, SR Radfar, H Mohaddes Ardabili, P Rafei, M Ebrahimi, ... Frontiers in psychiatry, 1134, 2021	72	2021
Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran S Zamani, R Radfar, P Nematollahi, R Fadaie, M Meshkati, S Mortazavi, ... International Journal of Drug Policy 21 (6), 493-500, 2010	64	2010
The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity? H Ekhtiari, A Noroozi, A Farhoudian, SR Radfar, A Hajebi, S Sefatian, ... Addiction 115 (7), 1395-1403, 2020	61	2020
Predictors of continued use of extended-released naltrexone (XR-NTX) for opioid-dependence: an analysis of heroin and non-heroin opioid users in Los Angeles County SJ Cousins, SR Radfar, D Crèvecoeur-MacPhail, A Ang, K Darfler, ... Journal of substance abuse treatment 63, 66-71, 2016	39	2016
Methamphetamine use among patients undergoing methadone maintenance treatment in Iran; a threat for harm reduction and treatment strategies: A qualitative study SR Radfar, SJ Cousins, S Shariatirad, A Noroozi, RA Rawson International Journal of High Risk Behaviors and Addiction 5 (4), 2016	33	2016
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran G Moradi, B Hajarizadeh, K Rahmani, A Mohamadi-Bolbanabad, ... International Journal of Drug Policy 73, 129-134, 2019	26	2019
Behaviors influencing human immunodeficiency virus transmission in the context of positive prevention among people living with HIV/acquired immunodeficiency syndrome in Iran: A … SR Radfar, A Sedaghat, AT Banihashemi, M Gouya, RA Rawson International Journal of Preventive Medicine 5 (8), 976, 2014	18	2014
Lead poisoning among opium users in Iran, a possible new emerging epidemic in the region SR Radfar, P Nematollahi, A Farhoudian, A Noroozi Iranian Journal of Public Health 46 (8), 1152-1153, 2017	15	2017
COVID-19 and substance use disorder: study protocol for the International Society of Addiction Medicine Practice and Policy Interest Group Global survey A Baldacchino, SR Radfar, C De Jong, P Rafei, M Yunesian, G Gerra, ... Basic and clinical neuroscience 11 (2), 155, 2020	12	2020
Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs M Alavia, A Moghanibashi-Mansouriehc, SR Radfar, S Alizadehe, ... International Journal of Drug Policy, 2020	12	2020
Integration of Methamphetamine Harm Reduction into Opioid Harm Reduction Services in Iran: Preliminary Results of a Pilot Study SR Radfar, S Mohsenifar, A Noroozi Iranian Journal of Psychiatry and Behavioral Sciences, 2017	12	2017
Practical guidelines on how to provide consulting services in behavioral disorders centers S Radfar, K Tayeri, H Namdari Tabar Tehran: Ministry of Health and Medical Education, 2009	12	2009
The Validity and Reliability of the Persian Version of the Leeds Dependence Questionnaire AF Omid Massah , Hassan Rafiey , Schwann Shariatirad , Seyed Ramin Radfar ... Iranian Rehabilitation Journal 17 (2), 91-96, 2019	8	2019
Factors influencing access and use of care and treatment services among Iranian people living with HIV and AIDS: a qualitative study SR Radfar, P Nematollahi, M Arasteh Iranian Journal of Public Health 45 (1), 109-111, 2016	8	2016
COVID-19 and substance use disorders: recommendations to a comprehensive healthcare response. An international society of addiction medicine practice and policy interest group … A Farhoudian, A Baldacchino, N Clark, G Gerra, H Ekhtiari, G Dom, ...	6	2020
Study on Prevalence of Alcohol Abuse among Injecting Drug Users in Tehran and 5 Major Cities of Iran SR Radfar, A Noroozi, K Tayeri, A Motavalian, P Nematollahi, ... Asia Pacific Journal of Medical Toxicology 3 (Supplement 1), 20-20, 2014	6	2014
Prevalence of latent tuberculosis infection and HIV among people who inject drugs in Iran SR Radfar, P Nematollahi, K Tayeri, H Dehghan, M Janani, P Higgs, ... Drug and Alcohol Review 40 (4), 572-579, 2021	5	2021

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori